Page last updated: 2024-09-04

2-n,n-di-n-propylamino-4,7-dimethoxyindan and methylatropine

2-n,n-di-n-propylamino-4,7-dimethoxyindan has been researched along with methylatropine in 1 studies

Compound Research Comparison

Studies
(2-n,n-di-n-propylamino-4,7-dimethoxyindan)
Trials
(2-n,n-di-n-propylamino-4,7-dimethoxyindan)
Recent Studies (post-2010)
(2-n,n-di-n-propylamino-4,7-dimethoxyindan)
Studies
(methylatropine)
Trials
(methylatropine)
Recent Studies (post-2010) (methylatropine)
16004161225

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arnerić, SP; Long, JP1

Other Studies

1 other study(ies) available for 2-n,n-di-n-propylamino-4,7-dimethoxyindan and methylatropine

ArticleYear
Evidence that a novel dopamine receptor agonist, RDS-127 [2-di-n-propylamino-4,7-dimethoxyindane] has some centrally mediated cardiovascular actions.
    The Journal of pharmacy and pharmacology, 1984, Volume: 36, Issue:5

    Topics: Animals; Atropine Derivatives; Blood Pressure; Brain; Drug Interactions; Haloperidol; Heart Rate; Hemodynamics; Indans; Indenes; Injections, Intravenous; Injections, Intraventricular; Male; Phentolamine; Rats; Rats, Inbred Strains; Receptors, Dopamine

1984